Autophagy in load-induced heart disease - PubMed (original) (raw)
Review
Autophagy in load-induced heart disease
Beverly A Rothermel et al. Circ Res. 2008.
Abstract
The heart is a highly plastic organ capable of remodeling in response to changes in physiological or pathological demand. For example, when workload increases, compensatory hypertrophic growth of individual cardiomyocytes occurs to increase cardiac output. Sustained stress, however, such as that occurring with hypertension or following myocardial infarction, triggers changes in energy metabolism and sarcomeric protein composition, loss of cardiomyocytes, ventricular dilation, reduced pump function, and ultimately heart failure. It has been known for some time that autophagy is active in cardiomyocytes, occurring at increased levels in disease. Now, with recent advances in our understanding of molecular mechanisms governing autophagy, the potential contributions of cardiomyocyte autophagy to ventricular remodeling and disease pathogenesis are being explored. As part of this work, several recent studies have focused on autophagy in heart disease elicited by changes in hemodynamic load. Pressure overload stress elicits a robust autophagic response in cardiomyocytes that is maladaptive, contributing to disease progression. In this context, load-induced aggregation of intracellular proteins is a proximal event triggering autophagic clearance mechanisms. These findings in the setting of pressure overload contrast with protein aggregation occurring in a model of protein chaperone malfunction, where activation of autophagy is beneficial, antagonizing disease progression. Here, we review recent studies of cardiomyocyte autophagy in load-induced disease and address molecular mechanisms and unanswered questions.
Figures
Figure 1
Working model of the dual nature of autophagy in heart disease. Basal activation of autophagy is required for normal cellular function. Too little or too much autophagy can each be maladaptive. Hemodynamic stress triggers autophagy, which, depending on the amplitude and duration of autophagic activation and the initial level of basal autophagic flux, may elicit either harmful or beneficial effects.
Figure 2
Working model of autophagic activation in load-induced heart disease. Hemo-dynamic stress triggers an autophagic response via multiple mechanisms, including protein damage/aggregation, ROS accumulation, Ca2+ overload, and nutrient deprivation. Downstream interplay among these pathways elicits an autophagic response. Opening of the mitochondrial permeability transition pore may elicit selective targeting of damaged mitochondria. In parallel, misfolded proteins are degraded by the ubiquitin– proteasome system, as well as sequestered into aggregates and aggresomes.
Similar articles
- Autophagy in load-induced heart disease.
Zhu H, Rothermel BA, Hill JA. Zhu H, et al. Methods Enzymol. 2009;453:343-63. doi: 10.1016/S0076-6879(08)04017-2. Methods Enzymol. 2009. PMID: 19216915 Free PMC article. - The heart of autophagy: deconstructing cardiac proteotoxicity.
Rothermel BA, Hill JA. Rothermel BA, et al. Autophagy. 2008 Oct;4(7):932-5. doi: 10.4161/auto.6756. Epub 2008 Oct 8. Autophagy. 2008. PMID: 18769158 Free PMC article. - Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy.
Tannous P, Zhu H, Nemchenko A, Berry JM, Johnstone JL, Shelton JM, Miller FJ Jr, Rothermel BA, Hill JA. Tannous P, et al. Circulation. 2008 Jun 17;117(24):3070-8. doi: 10.1161/CIRCULATIONAHA.107.763870. Epub 2008 Jun 9. Circulation. 2008. PMID: 18541737 Free PMC article. - Autophagy in hypertensive heart disease.
Wang ZV, Rothermel BA, Hill JA. Wang ZV, et al. J Biol Chem. 2010 Mar 19;285(12):8509-14. doi: 10.1074/jbc.R109.025023. Epub 2010 Jan 29. J Biol Chem. 2010. PMID: 20118246 Free PMC article. Review. - Role of autophagy in heart failure associated with aging.
De Meyer GR, De Keulenaer GW, Martinet W. De Meyer GR, et al. Heart Fail Rev. 2010 Sep;15(5):423-30. doi: 10.1007/s10741-010-9166-6. Heart Fail Rev. 2010. PMID: 20383579 Review.
Cited by
- Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
Liu L, Wang C, Lin Y, Xi Y, Li H, Shi S, Li H, Zhang W, Zhao Y, Tian Y, Xu C, Wang L. Liu L, et al. Mol Med Rep. 2016 Jul;14(1):111-20. doi: 10.3892/mmr.2016.5279. Epub 2016 May 13. Mol Med Rep. 2016. PMID: 27176663 Free PMC article. - Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation.
Pan L, Li Y, Jia L, Qin Y, Qi G, Cheng J, Qi Y, Li H, Du J. Pan L, et al. PLoS One. 2012;7(4):e35315. doi: 10.1371/journal.pone.0035315. Epub 2012 Apr 30. PLoS One. 2012. PMID: 22558139 Free PMC article. - Histochemistry and cell biology: the annual review 2010.
Hübner S, Efthymiadis A. Hübner S, et al. Histochem Cell Biol. 2011 Feb;135(2):111-40. doi: 10.1007/s00418-011-0781-7. Epub 2011 Jan 29. Histochem Cell Biol. 2011. PMID: 21279376 Review. - Ablation of ALCAT1 mitigates hypertrophic cardiomyopathy through effects on oxidative stress and mitophagy.
Liu X, Ye B, Miller S, Yuan H, Zhang H, Tian L, Nie J, Imae R, Arai H, Li Y, Cheng Z, Shi Y. Liu X, et al. Mol Cell Biol. 2012 Nov;32(21):4493-504. doi: 10.1128/MCB.01092-12. Epub 2012 Sep 4. Mol Cell Biol. 2012. PMID: 22949503 Free PMC article. - Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies.
Zheng Q, Li J, Wang X. Zheng Q, et al. Int J Physiol Pathophysiol Pharmacol. 2009 May 8;1(2):127-42. Int J Physiol Pathophysiol Pharmacol. 2009. PMID: 20411034 Free PMC article.
References
- Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146. - PubMed
- Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562. - PubMed
- Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–991. - PubMed
- Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109:1580–1589. - PubMed
- Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–1380. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL080144-01A2/HL/NHLBI NIH HHS/United States
- R01 HL097768/HL/NHLBI NIH HHS/United States
- R01 HL072016-05/HL/NHLBI NIH HHS/United States
- R01 HL075173/HL/NHLBI NIH HHS/United States
- R01 HL080144-02/HL/NHLBI NIH HHS/United States
- R01 HL072016-06A1/HL/NHLBI NIH HHS/United States
- R01 HL072016-03/HL/NHLBI NIH HHS/United States
- R01 HL075173-02/HL/NHLBI NIH HHS/United States
- R01 HL072016-02/HL/NHLBI NIH HHS/United States
- R01 HL072016/HL/NHLBI NIH HHS/United States
- R01 HL075173-04/HL/NHLBI NIH HHS/United States
- HL-080144/HL/NHLBI NIH HHS/United States
- R01 HL072016-01/HL/NHLBI NIH HHS/United States
- R01 HL075173-01A2/HL/NHLBI NIH HHS/United States
- R01 HL075173-03/HL/NHLBI NIH HHS/United States
- R01 HL072016-04/HL/NHLBI NIH HHS/United States
- R01 HL080144/HL/NHLBI NIH HHS/United States
- HL-075173/HL/NHLBI NIH HHS/United States
- HL-72016/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials